MEHTA API Pvt. Ltd.
Overview
Pharmaceutical manufacturing site surfaced via EU GMP non-compliance screening (EudraGMDP).
Core services & business areas
Active pharmaceutical ingredients supplied
Substances MEHTA API Pvt. Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
MEHTA API Pvt. Ltd. holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- VISMODEGIB IHActive2026-03-16
- AGOMELATINE IHActive2026-02-03
- CINACALCET HYDROCHLORIDE IHActive2025-12-08
- DROPERIDOL USPActive2025-07-02
- LANDIOLOL HYDROCHLORIDEActive2025-01-29
- MIRABEGRON EPActive2024-10-18
- CARIPRAZINE HYDROCHLORIDE IHActive2024-09-12
- ESMOLOL HCL USPActive2024-01-31
FDA compliance signals
1 FDA enforcement record linked to this company.
- eu_noncompliance2019-11-25
EU GMP Statement of Non-Compliance
Is this MEHTA API Pvt. Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.